PUBLISHER: Fortune Business Insights Pvt. Ltd. | PRODUCT CODE: 1933362
PUBLISHER: Fortune Business Insights Pvt. Ltd. | PRODUCT CODE: 1933362
Poultry Vaccines Market Size, Share, Growth and Global Industry Analysis By Type & Application, Regional Insights and Forecast to 2026-2034
Growth Factors of poultry vaccines Market
The global poultry vaccines market was valued at USD 1.32 billion in 2025 and is projected to reach USD 1.38 billion in 2026, eventually growing to USD 2.38 billion by 2034, reflecting a CAGR of 6.99% during the forecast period. The market is primarily driven by the rising demand for poultry products, increasing incidences of infectious poultry diseases such as avian influenza, Newcastle disease, and infectious bronchitis, and growing awareness about biosecurity and disease prevention among poultry farmers. North America dominated the market in 2025 with a 46.11% share, supported by stringent regulations, robust healthcare infrastructure for poultry, and the presence of leading vaccine manufacturers. Key players such as Zoetis Services LLC, Merck & Co., Inc., and Boehringer Ingelheim International GmbH hold strong market positions due to broad product portfolios and extensive geographic presence.
Market Dynamics
Drivers: The most significant driver of the poultry vaccines market is the increasing consumption of poultry meat and eggs globally. A growing population has led to higher demand for animal-based protein, making flock health critical to maintaining food security and nutritional quality. Vaccination reduces disease outbreaks, prevents economic losses, and ensures a steady supply of poultry products. For instance, as per the U.S. Department of Agriculture, 21.34 million metric tons of chicken meat were produced in the U.S. during 2024/2025, accounting for around 21% of global production, highlighting the importance of disease-free flocks.
Restraints: Vaccine failures and "leaky vaccines" pose significant market challenges. Rapidly mutating diseases like Marek's disease and avian influenza can reduce vaccine efficacy, causing flock mortality of 10-40% even in vaccinated populations. These failures result in economic losses, farmer dissatisfaction, and slowed adoption of vaccines.
Opportunities: Government vaccination campaigns offer growth potential. For example, in April 2025, India's Department of Animal Husbandry & Dairying collaborated with the poultry industry to offer vaccines against Highly Pathogenic Avian Influenza (HPAI). Such initiatives ensure uniform immunity coverage, mitigate disease outbreaks, and provide opportunities for market expansion.
Challenges: Supply chain disruptions and storage issues remain critical barriers. Poultry vaccines must be stored at 2-8°C to remain effective, and inadequate cold chain infrastructure in lower-middle-income countries can lead to degradation, poor immune responses, and higher wastage.
Market Trends
The industry is witnessing a shift toward in-ovo vaccination technology, where vaccines are injected into eggs on day 18 of incubation. This method offers immunity before hatching, reduces handling stress, and ensures uniform coverage. Companies like HIPRA have launched in-ovo vaccines such as EVANOVO in Europe, exemplifying this trend toward automation and efficiency in large-scale poultry operations.
Segmentation Analysis
By Technology: The market includes inactivated, live attenuated, recombinant, and other vaccines. Inactivated vaccines dominate due to their effectiveness in preventing outbreaks and growing demand for animal protein. For instance, in February 2025, Zoetis Services LLC received USDA conditional approval for its H5N2 Avian Influenza vaccine.
By Disease Type: Viral disease vaccines hold the largest market share, addressing threats from avian influenza, Newcastle disease, and Marek's disease. Boehringer Ingelheim launched a three-in-one vaccine in India (Nov 2024) for these viral diseases, boosting segment growth.
By Route of Administration: Parenteral vaccines dominate due to precise dosing and stronger immune responses. For example, in March 2024, Merck & Co., Inc. obtained European approval for NOBILIS MULTRIVA REOm for intramuscular use in chickens.
By Distribution Channel: Veterinary hospitals lead in distribution due to government-backed vaccination programs and proactive veterinary services. In June 2025, South Africa launched a mass HPAI vaccination campaign through veterinary channels.
Regional Outlook
North America: Dominates with a USD 0.61 billion market size in 2025, driven by regulations, key industry players, and strong R&D investments. The U.S. Department of Agriculture funded USD 100 million in April 2025 for avian influenza vaccine research.
Europe: Expected to reach USD 0.36 billion in 2025, growing at 5.97%, supported by rising poultry product demand and biosecurity awareness.
Asia Pacific: Holds the third-largest market with USD 0.17 billion in 2025, driven by increasing poultry consumption and vaccine adoption.
Latin America & Middle East & Africa: Moderate growth is projected, with 2025 valuations at USD 0.11 billion and USD 0.06 billion, respectively, supported by government initiatives to improve poultry health.
Competitive Landscape
The market is semi-fragmented, with dominant players including Zoetis Services LLC, Merck & Co., Inc., Boehringer Ingelheim International GmbH, Elanco, Ceva, HIPRA, and Bioveta, a.s. These companies focus on product launches, strategic partnerships, and geographic expansion to maintain their leadership. Key industry developments include Bioveta launching an inactivated vaccine against bacterial pasteurellosis (July 2025) and Virbac acquiring Globion (Oct 2023) to expand its India operations.
Conclusion
The global poultry vaccines market is set to grow from USD 1.32 billion in 2025 to USD 1.38 billion in 2026, reaching USD 2.38 billion by 2034 at a CAGR of 6.99%. Market expansion is fueled by rising poultry consumption, outbreaks of infectious diseases, government vaccination campaigns, and innovations such as in-ovo vaccination. While challenges like vaccine failures and cold chain limitations persist, opportunities in technological advancement, product launches, and strategic government initiatives are likely to sustain market growth. Leading companies' strong R&D focus and portfolio diversification further consolidate their market position.
Segmentation By Technology
- Inactivated
- Live Attenuated
- Recombinant
- Others
By Disease Type
- Viral Diseases
- Avian Influenza
- Newcastle Disease
- Marek's Disease
- Others
- Bacterial Diseases
- Salmonellosis
- Mycoplasmosis
- Others
- Parasitic Diseases
By Route of Administration
- Parenteral
- Intranasal
- Others
By Distribution Channel
- Veterinary Hospitals
- Veterinary Clinics
- Pharmacies & Drug Stores
- Others
By Region
- North America (By Technology, Disease Type, Route of Administration, Distribution Channel, and Country)
- U.S.
- Canada
- Europe (By Technology, Disease Type, Route of Administration, Distribution Channel, and Country/Sub-region)
- Germany
- U.K.
- France
- Spain
- Italy
- Scandinavia
- Rest of Europe
- Asia Pacific (By Technology, Disease Type, Route of Administration, Distribution Channel, and Country/Sub-region)
- China
- Japan
- India
- Australia
- Southeast Asia
- Rest of Asia Pacific
- Latin America (By Technology, Disease Type, Route of Administration, Distribution Channel, and Country/Sub-region)
- Brazil
- Mexico
- Rest of Latin America
- Middle East & Africa (By Technology, Disease Type, Route of Administration, Distribution Channel, and Country/Sub-region)
- GCC
- South Africa
- Rest of the Middle East & Africa
Table of Content
1. Introduction
- 1.1. Research Scope
- 1.2. Market Segmentation
- 1.3. Research Methodology
- 1.4. Definitions and Assumptions
2. Executive Summary
3. Market Dynamics
- 3.1. Market Drivers
- 3.2. Market Restraints
- 3.3. Market Opportunities
- 3.4. Market Trends
- 3.5. Market Challenges
4. Key Insights
- 4.1. Overview of Poultry Diseases by Key Countries, By Key Countries/ Region, 2025
- 4.2. Regulatory Scenario by Key Countries/ Region, 2025
- 4.3. Overview of Vaccination for Poultry Diseases
- 4.4. New Technology Launches, By Key Players
- 4.5. Key Industry Developments (Mergers, Acquisitions, Partnerships, etc.)
5. Global Poultry Vaccines Market Analysis, Insights and Forecast, 2021-2034
- 5.1. Market Analysis, Insights and Forecast - By Technology
- 5.1.1. Inactivated
- 5.1.2. Live Attenuated
- 5.1.3. Recombinant
- 5.1.4. Others
- 5.2. Market Analysis, Insights and Forecast - By Disease Type
- 5.2.1. Viral Diseases
- 5.2.1.1. Avian Influenza
- 5.2.1.2. Newcastle Disease
- 5.2.1.3. Marek's Disease
- 5.2.1.4. Others
- 5.2.2. Bacterial Diseases
- 5.2.2.1. Salmonellosis
- 5.2.2.2. Mycoplasmosis
- 5.2.2.3. Others
- 5.2.3. Parasitic Diseases
- 5.2.1. Viral Diseases
- 5.3. Market Analysis, Insights and Forecast - By Route of Administration
- 5.3.1. Parenteral
- 5.3.2. Intranasal
- 5.3.3. Others
- 5.4. Market Analysis, Insights and Forecast - By Distribution Channel
- 5.4.1. Veterinary Hospitals
- 5.4.2. Veterinary Clinics
- 5.4.3. Pharmacies & Drug Stores
- 5.4.4. Others
- 5.5. Market Analysis, Insights and Forecast - Region
- 5.5.1. North America
- 5.5.2. Europe
- 5.5.3. Asia Pacific
- 5.5.4. Latin America
- 5.5.5. Middle East & Africa
6. North America Poultry Vaccines Market Analysis, Insights and Forecast, 2021-2034
- 6.1. Market Analysis, Insights and Forecast - By Technology
- 6.1.1. Inactivated
- 6.1.2. Live Attenuated
- 6.1.3. Recombinant
- 6.1.4. Others
- 6.2. Market Analysis, Insights and Forecast - By Disease Type
- 6.2.1. Poultry Influenza
- 6.2.2. Lyme Disease
- 6.2.3. Rabies
- 6.2.4. Leptospirosis
- 6.2.5. Others
- 6.3. Market Analysis, Insights and Forecast - By Route of Administration
- 6.3.1. Oral
- 6.3.2. Parenteral
- 6.3.3. Intranasal
- 6.4. Market Analysis, Insights and Forecast - By Distribution Channel
- 6.4.1. Veterinary Hospitals
- 6.4.2. Veterinary Clinics
- 6.4.3. Pharmacies & Drug Stores
- 6.4.4. Others
- 6.5. Market Analysis, Insights and Forecast - By Country
- 6.5.1. U.S.
- 6.5.2. Canada
7. Europe Poultry Vaccines Market Analysis, Insights and Forecast, 2021-2034
- 7.1. Market Analysis, Insights and Forecast - By Technology
- 7.1.1. Inactivated
- 7.1.2. Live Attenuated
- 7.1.3. Recombinant
- 7.1.4. Others
- 7.2. Market Analysis, Insights and Forecast - By Disease Type
- 7.2.1. Viral Diseases
- 7.2.1.1. Avian Influenza
- 7.2.1.2. Newcastle Disease
- 7.2.1.3. Marek's Disease
- 7.2.1.4. Others
- 7.2.2. Bacterial Diseases
- 7.2.2.1. Salmonellosis
- 7.2.2.2. Mycoplasmosis
- 7.2.2.3. Others
- 7.2.3. Parasitic Diseases
- 7.2.1. Viral Diseases
- 7.3. Market Analysis, Insights and Forecast - By Route of Administration
- 7.3.1. Parenteral
- 7.3.2. Intranasal
- 7.3.3. Others
- 7.4. Market Analysis, Insights and Forecast - By Distribution Channel
- 7.4.1. Veterinary Hospitals
- 7.4.2. Veterinary Clinics
- 7.4.3. Pharmacies & Drug Stores
- 7.4.4. Others
- 7.5. Market Analysis, Insights and Forecast - By Country/ Sub-Region
- 7.5.1. Germany
- 7.5.2. U.K.
- 7.5.3. France
- 7.5.4. Italy
- 7.5.5. Spain
- 7.5.6. Scandinavia
- 7.5.7. Rest of Europe
8. Asia Pacific Poultry Vaccines Market Analysis, Insights and Forecast, 2021-2034
- 8.1. Market Analysis, Insights and Forecast - By Technology
- 8.1.1. Inactivated
- 8.1.2. Live Attenuated
- 8.1.3. Recombinant
- 8.1.4. Others
- 8.2. Market Analysis, Insights and Forecast - By Disease Type
- 8.2.1. Viral Diseases
- 8.2.1.1. Avian Influenza
- 8.2.1.2. Newcastle Disease
- 8.2.1.3. Marek's Disease
- 8.2.1.4. Others
- 8.2.2. Bacterial Diseases
- 8.2.2.1. Salmonellosis
- 8.2.2.2. Mycoplasmosis
- 8.2.2.3. Others
- 8.2.3. Parasitic Diseases
- 8.2.1. Viral Diseases
- 8.3. Market Analysis, Insights and Forecast - By Route of Administration
- 8.3.1. Parenteral
- 8.3.2. Intranasal
- 8.3.3. Others
- 8.4. Market Analysis, Insights and Forecast - By Distribution Channel
- 8.4.1. Veterinary Hospitals
- 8.4.2. Veterinary Clinics
- 8.4.3. Pharmacies & Drug Stores
- 8.4.4. Others
- 8.5. Market Analysis, Insights and Forecast - By Country/ Sub-Region
- 8.5.1. China
- 8.5.2. Japan
- 8.5.3. India
- 8.5.4. Australia
- 8.5.5. Southeast Asia
- 8.5.6. Rest of Asia Pacific
9. Latin America Poultry Vaccines Market Analysis, Insights and Forecast, 2021-2034
- 9.1. Market Analysis, Insights and Forecast - By Technology
- 9.1.1. Inactivated
- 9.1.2. Live Attenuated
- 9.1.3. Recombinant
- 9.1.4. Others
- 9.2. Market Analysis, Insights and Forecast - By Disease Type
- 9.2.1. Viral Diseases
- 9.2.1.1. Avian Influenza
- 9.2.1.2. Newcastle Disease
- 9.2.1.3. Marek's Disease
- 9.2.1.4. Others
- 9.2.2. Bacterial Diseases
- 9.2.2.1. Salmonellosis
- 9.2.2.2. Mycoplasmosis
- 9.2.2.3. Others
- 9.2.3. Parasitic Diseases
- 9.2.1. Viral Diseases
- 9.3. Market Analysis, Insights and Forecast - By Route of Administration
- 9.3.1. Parenteral
- 9.3.2. Intranasal
- 9.3.3. Others
- 9.4. Market Analysis, Insights and Forecast - By Distribution Channel
- 9.4.1. Veterinary Hospitals
- 9.4.2. Veterinary Clinics
- 9.4.3. Pharmacies & Drug Stores
- 9.4.4. Others
- 9.5. Market Analysis, Insights and Forecast - By Country/ Sub-Region
- 9.5.1. Brazil
- 9.5.2. Mexico
- 9.5.3. Rest of Latin America
10. Middle East & Africa Poultry Vaccines Market Analysis, Insights and Forecast, 2021-2034
- 10.1. Market Analysis, Insights and Forecast - By Technology
- 10.1.1. Inactivated
- 10.1.2. Live Attenuated
- 10.1.3. Recombinant
- 10.1.4. Others
- 10.2. Market Analysis, Insights and Forecast - By Disease Type
- 10.2.1. Viral Diseases
- 10.2.1.1. Avian Influenza
- 10.2.1.2. Newcastle Disease
- 10.2.1.3. Marek's Disease
- 10.2.1.4. Others
- 10.2.2. Bacterial Diseases
- 10.2.2.1. Salmonellosis
- 10.2.2.2. Mycoplasmosis
- 10.2.2.3. Others
- 10.2.3. Parasitic Diseases
- 10.2.1. Viral Diseases
- 10.3. Market Analysis, Insights and Forecast - By Route of Administration
- 10.3.1. Parenteral
- 10.3.2. Intranasal
- 10.3.3. Others
- 10.4. Market Analysis, Insights and Forecast - By Distribution Channel
- 10.4.1. Veterinary Hospitals
- 10.4.2. Veterinary Clinics
- 10.4.3. Pharmacies & Drug Stores
- 10.4.4. Others
- 10.5. Market Analysis, Insights and Forecast - By Country/ Sub-Region
- 10.5.1. GCC
- 10.5.2. South Africa
- 10.5.3. Rest of Middle East & Africa
11. Competitive Analysis
- 11.1. Global Market Share Analysis (2025)
- 11.2. Company Profiles (Overview, Technology, SWOT analysis, Recent developments, strategies, financials (based on availability))
- 11.2.1. Elanco
- 11.2.2. Boehringer Ingelheim International GmbH
- 11.2.3. Virbac
- 11.2.4. Merck & Co., Inc.
- 11.2.5. Zoetis Services LLC
- 11.2.6. Ceva
- 11.2.7. Bioveta, a.s.
- 11.2.8. Indian Immunologicals Ltd.
- 11.2.9. HIPRA
List of Tables
- Table 1: Global Poultry Vaccines Market Revenue (USD billion) Forecast, by Technology, 2021-2034
- Table 2: Global Poultry Vaccines Market Revenue (USD billion) Forecast, by Disease Type, 2021-2034
- Table 3: Global Poultry Vaccines Market Revenue (USD billion) Forecast, by Viral Diseases, 2021-2034
- Table 4: Global Poultry Vaccines Market Revenue (USD billion) Forecast, by Bacterial Diseases, 2021-2034
- Table 5: Global Poultry Vaccines Market Revenue (USD billion) Forecast, by Route of Administration, 2021-2034
- Table 6: Global Poultry Vaccines Market Revenue (USD billion) Forecast, by Distribution Channel, 2021-2034
- Table 7: Global Poultry Vaccines Market Revenue (USD billion) Forecast, by Region, 2021-2034
- Table 8: North America Poultry Vaccines Market Revenue (USD billion) Forecast, by Technology, 2021-2034
- Table 9: North America Poultry Vaccines Market Revenue (USD billion) Forecast, by Disease Type, 2021-2034
- Table 10: North America Poultry Vaccines Market Revenue (USD billion) Forecast, by Viral Diseases, 2021-2034
- Table 11: North America Poultry Vaccines Market Revenue (USD billion) Forecast, by Bacterial Diseases, 2021-2034
- Table 12: North America Poultry Vaccines Market Revenue (USD billion) Forecast, by Route of Administration, 2021-2034
- Table 13: North America Poultry Vaccines Market Revenue (USD billion) Forecast, by Distribution Channel, 2021-2034
- Table 14: North America Poultry Vaccines Market Revenue (USD billion) Forecast, By Country, 2021-2034
- Table 15: Europe Poultry Vaccines Market Revenue (USD billion) Forecast, by Technology, 2021-2034
- Table 16: Europe Poultry Vaccines Market Revenue (USD billion) Forecast, by Disease Type, 2021-2034
- Table 17: Europe Poultry Vaccines Market Revenue (USD billion) Forecast, by Viral Diseases, 2021-2034
- Table 18: Europe Poultry Vaccines Market Revenue (USD billion) Forecast, by Bacterial Diseases, 2021-2034
- Table 19: Europe Poultry Vaccines Market Revenue (USD billion) Forecast, by Route of Administration, 2021-2034
- Table 20: Europe Poultry Vaccines Market Revenue (USD billion) Forecast, by Distribution Channel, 2021-2034
- Table 21: Europe Poultry Vaccines Market Revenue (USD billion) Forecast, By Country/ Sub-region, 2021-2034
- Table 22: Asia Pacific Poultry Vaccines Market Revenue (USD billion) Forecast, by Technology, 2021-2034
- Table 23: Asia Pacific Poultry Vaccines Market Revenue (USD billion) Forecast, by Disease Type, 2021-2034
- Table 24: Asia Pacific Poultry Vaccines Market Revenue (USD billion) Forecast, by Viral Diseases, 2021-2034
- Table 25: Asia Pacific Poultry Vaccines Market Revenue (USD billion) Forecast, by Bacterial Diseases, 2021-2034
- Table 26: Asia Pacific Poultry Vaccines Market Revenue (USD billion) Forecast, by Route of Administration, 2021-2034
- Table 27: Asia Pacific Poultry Vaccines Market Revenue (USD billion) Forecast, by Distribution Channel, 2021-2034
- Table 28: Asia Pacific Poultry Vaccines Market Revenue (USD billion) Forecast, By Country/ Sub-region, 2021-2034
- Table 29: Latin America Poultry Vaccines Market Revenue (USD billion) Forecast, by Technology, 2021-2034
- Table 30: Latin America Poultry Vaccines Market Revenue (USD billion) Forecast, by Disease Type, 2021-2034
- Table 31: Latin America Poultry Vaccines Market Revenue (USD billion) Forecast, by Viral Diseases, 2021-2034
- Table 32: Latin America Poultry Vaccines Market Revenue (USD billion) Forecast, by Bacterial Diseases, 2021-2034
- Table 33: Latin America Poultry Vaccines Market Revenue (USD billion) Forecast, by Route of Administration, 2021-2034
- Table 34: Latin America Poultry Vaccines Market Revenue (USD billion) Forecast, by Distribution Channel, 2021-2034
- Table 35: Latin America Poultry Vaccines Market Revenue (USD billion) Forecast, By Country/ Sub-region, 2021-2034
- Table 36: Middle East & Africa Poultry Vaccines Market Revenue (USD billion) Forecast, by Technology, 2021-2034
- Table 37: Middle East & Africa Poultry Vaccines Market Revenue (USD billion) Forecast, by Disease Type, 2021-2034
- Table 38: Middle East & Africa Poultry Vaccines Market Revenue (USD billion) Forecast, by Viral Diseases, 2021-2034
- Table 39: Middle East & Africa Poultry Vaccines Market Revenue (USD billion) Forecast, by Bacterial Diseases, 2021-2034
- Table 40: Middle East & Africa Poultry Vaccines Market Revenue (USD billion) Forecast, by Route of Administration, 2021-2034
- Table 41: Middle East & Africa Poultry Vaccines Market Revenue (USD billion) Forecast, by Distribution Channel, 2021-2034
- Table 42: Middle East & Africa Poultry Vaccines Market Revenue (USD billion) Forecast, By Country/ Sub-region, 2021-2034
List of Figures
- Figure 1: Global Poultry Vaccines Market Revenue Breakdown (USD billion, %) by Region, 2025 & 2034
- Figure 2: Global Poultry Vaccines Market Value Share (%), by Technology, 2025 & 2034
- Figure 3: Global Poultry Vaccines Market Value Share (%), by Disease Type, 2025 & 2034
- Figure 4: Global Poultry Vaccines Market Value Share (%), by Route of Administration, 2025 & 2034
- Figure 5: Global Poultry Vaccines Market Value Share (%), by Distribution Channel, 2025 & 2034
- Figure 6: Global Poultry Vaccines Market Value Share (%), by Region, 2025 & 2034
- Figure 7: North America Poultry Vaccines Market Value (USD billion), by Technology, 2025 & 2034
- Figure 8: North America Poultry Vaccines Market Value Share (%), by Technology, 2025
- Figure 9: North America Poultry Vaccines Market Value (USD billion), by Disease Type, 2025 & 2034
- Figure 10: North America Poultry Vaccines Market Value Share (%), by Disease Type, 2025
- Figure 11: North America Poultry Vaccines Market Value (USD billion), by Route of Administration, 2025 & 2034
- Figure 12: North America Poultry Vaccines Market Value Share (%), by Route of Administration, 2025
- Figure 13: North America Poultry Vaccines Market Value (USD billion), by Distribution Channel, 2025 & 2034
- Figure 14: North America Poultry Vaccines Market Value Share (%), by Distribution Channel, 2025
- Figure 15: North America Poultry Vaccines Market Value (USD billion), By Country, 2025 & 2034
- Figure 16: North America Poultry Vaccines Market Value Share (%), By Country, 2025
- Figure 17: Europe Poultry Vaccines Market Value (USD billion), by Technology, 2025 & 2034
- Figure 18: Europe Poultry Vaccines Market Value Share (%), by Technology, 2025
- Figure 19: Europe Poultry Vaccines Market Value (USD billion), by Disease Type, 2025 & 2034
- Figure 20: Europe Poultry Vaccines Market Value Share (%), by Disease Type, 2025
- Figure 21: Europe Poultry Vaccines Market Value (USD billion), by Route of Administration, 2025 & 2034
- Figure 22: Europe Poultry Vaccines Market Value Share (%), by Route of Administration, 2025
- Figure 23: Europe Poultry Vaccines Market Value (USD billion), by Distribution Channel, 2025 & 2034
- Figure 24: Europe Poultry Vaccines Market Value Share (%), by Distribution Channel, 2025
- Figure 25: Europe Poultry Vaccines Market Value (USD billion), By Country/ Sub-region, 2025 & 2034
- Figure 26: Europe Poultry Vaccines Market Value Share (%), By Country/ Sub-region, 2025
- Figure 27: Asia Pacific Poultry Vaccines Market Value (USD billion), by Technology, 2025 & 2034
- Figure 28: Asia Pacific Poultry Vaccines Market Value Share (%), by Technology, 2025
- Figure 29: Asia Pacific Poultry Vaccines Market Value (USD billion), by Disease Type, 2025 & 2034
- Figure 30: Asia Pacific Poultry Vaccines Market Value Share (%), by Disease Type, 2025
- Figure 31: Asia Pacific Poultry Vaccines Market Value (USD billion), by Route of Administration, 2025 & 2034
- Figure 32: Asia Pacific Poultry Vaccines Market Value Share (%), by Route of Administration, 2025
- Figure 33: Asia Pacific Poultry Vaccines Market Value (USD billion), by Distribution Channel, 2025 & 2034
- Figure 34: Asia Pacific Poultry Vaccines Market Value Share (%), by Distribution Channel, 2025
- Figure 35: Asia Pacific Poultry Vaccines Market Value (USD billion), By Country/ Sub-region, 2025 & 2034
- Figure 36: Asia Pacific Poultry Vaccines Market Value Share (%), By Country/ Sub-region, 2025
- Figure 37: Latin America Poultry Vaccines Market Value (USD billion), by Technology, 2025 & 2034
- Figure 38: Latin America Poultry Vaccines Market Value Share (%), by Technology, 2025
- Figure 39: Latin America Poultry Vaccines Market Value (USD billion), by Disease Type, 2025 & 2034
- Figure 40: Latin America Poultry Vaccines Market Value Share (%), by Disease Type, 2025
- Figure 41: Latin America Poultry Vaccines Market Value (USD billion), by Route of Administration, 2025 & 2034
- Figure 42: Latin America Poultry Vaccines Market Value Share (%), by Route of Administration, 2025
- Figure 43: Latin America Poultry Vaccines Market Value (USD billion), by Distribution Channel, 2025 & 2034
- Figure 44: Latin America Poultry Vaccines Market Value Share (%), by Distribution Channel, 2025
- Figure 45: Latin America Poultry Vaccines Market Value (USD billion), By Country/ Sub-region, 2025 & 2034
- Figure 46: Latin America Poultry Vaccines Market Value Share (%), By Country/ Sub-region, 2025
- Figure 47: Middle East & Africa Poultry Vaccines Market Value (USD billion), by Technology, 2025 & 2034
- Figure 48: Middle East & Africa Poultry Vaccines Market Value Share (%), by Technology, 2025
- Figure 49: Middle East & Africa Poultry Vaccines Market Value (USD billion), by Disease Type, 2025 & 2034
- Figure 50: Middle East & Africa Poultry Vaccines Market Value Share (%), by Disease Type, 2025
- Figure 51: Middle East & Africa Poultry Vaccines Market Value (USD billion), by Route of Administration, 2025 & 2034
- Figure 52: Middle East & Africa Poultry Vaccines Market Value Share (%), by Route of Administration, 2025
- Figure 53: Middle East & Africa Poultry Vaccines Market Value (USD billion), by Distribution Channel, 2025 & 2034
- Figure 54: Middle East & Africa Poultry Vaccines Market Value Share (%), by Distribution Channel, 2025
- Figure 55: Middle East & Africa Poultry Vaccines Market Value (USD billion), By Country/ Sub-region, 2025 & 2034
- Figure 56: Middle East & Africa Poultry Vaccines Market Value Share (%), By Country/ Sub-region, 2025
- Figure 57: Global Poultry Vaccines Market Share (%), By Company, 2025
